Representative Matters
REFERENZMANDATE
代表事项
Dr. Ashraf has represented life science companies, ranging in size from start-ups to public companies, and academic institutions, including: NovaHep AB (Sweden)*; Chimerix, Inc.*; Acorda Therapeutics, Inc.*; Intarcia Therapeutics, Inc.*; University of Pittsburgh*; Celldex Therapeutics, Inc.*; ForSight Labs.* and Valeant Pharmaceuticals International, Inc.*
* Denotes experience prior to joining Goodwin.
- Served as an outside patent counsel to Celldex Therapeutics, Inc. and managed four worldwide patent portfolios related to antibody-toxin conjugates for treating cancer*
- Served as outside patent counsel to NovaHep AB, Sweden and managed three worldwide patent portfolios related to personalized organs for regenerative medicine*
- Served as outside counsel to University of Pittsburgh’s patent portfolio on muscle-derived stem cells (MDSCs) and managed nine worldwide patent portfolios on tissue and organ regeneration with MDSCs*
- Managed nine worldwide patent portfolios of Acorda Therapeutics, Inc. relating to neuregulin growth factors for treating nervous and cardiac system diseases and disorders*
* Denotes experience prior to joining Goodwin.
- Performed IP due diligence in connection with a $35 million public offering*
- Performed numerous freedom-to-operate searches and patent validity analyses*
* Denotes experience prior to joining Goodwin.
Dr. Ashraf is a member of a number of professional organizations, including the American Intellectual Property Law Association, the American Bar Association, the Boston Bar Association and the Boston Patent Law Association.
Prior to joining Goodwin in 2016, Dr. Ashraf was an associate in the Intellectual Property group at Mintz Levin PC (Boston), and, prior to joining Mintz Levin, a Technical Specialist at Sterne, Kessler, Goldstein, & Fox (Washington, D.C.).